Skip to Main Content

Paper Details

Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
Histopathology
18
2020
AMEs, Breast adenomyoepitheliomas, ER, ER-, ER-negative, ER-negative AMEs, HRAS, HRAS Q61, HRAS Q61 hotspot, HRAS Q61 hotspot locus, HRAS Q61K mutations, HRAS Q61R, HRAS Q61R mutations, HRAS mutations, PI3K, PI3K pathway, PI3K pathway genes, Q61K, Q61K mutations, Q61R, RAS, RAS Q61R, RAS Q61R-specific antibody, breast AMEs, breast adenomyoepitheliomas, myoepithelial, myoepithelial component, oestrogen, oestrogen receptor, phosphoinositide 3-kinase, phosphoinositide 3-kinase (PI3K) pathway genes, tumours
Author NameAffiliation
Pier SelenicaMemorial Sloan-Kettering Cancer Center
Hannah Y WenMemorial Sloan-Kettering Cancer Center
Brian P RubinCleveland Clinic
Brian P RubinCleveland Clinic
Britta WeigeltMemorial Sloan-Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan-Kettering Cancer Center
  • 1 - 6

Datasets

Release 1.2